Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults.
Journal Article (Journal Article)
Clinical trials for Staphylococcus aureus bloodstream infections (SAB) are broadly grouped into 2 categories: registrational trials intended to support regulatory approval of antibiotics for the treatment of SAB and strategy trials intended to inform clinicians on the best treatment options for SAB among existing antibiotics. Both types of SAB trials are urgently needed but have been limited by cost, complexity, and regulatory uncertainty. Here, we review key SAB trial design considerations for investigators, sponsors, and regulators.
- Holland, TL; Chambers, HF; Boucher, HW; Corey, GR; Coleman, R; Castaneda-Ruiz, B; Fowler, VG
- February 15, 2019
- Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Volume / Issue
- 68 / 5
Start / End Page
- 865 - 872
Pubmed Central ID
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
- United States